- Volumes positive in all three Business Areas
- Revenue down 4 percent, mainly due to 5 percent adverse currency effects
- Operating income €353 million (2013: €322 million) reflecting increased volume and benefits from improvement actions
- Return on sales (ROS) improved from 8.3 percent to 9.5 percent. Restructuring costs were €45 million (2013: €40 million). Excluding these, ROS is 10.7 percent (2013: 9.3 percent)
- Net income attributable to shareholders was €205 million (2013: €184 million on a comparable basis), mainly due to higher operating income
- Adjusted EPS increased 23 percent to €0.95 (2013: €0.77 adjusted for an incidental tax gain)
- Net cash inflow from operating activities was €393 million (2013: €261 million)
- On track to deliver 2015 targets despite a strong euro and the expected continued fragile economic environment in 2014
Q2 2014 Report (PDF, 377kb)
Quarterly Results overview page
Akzo Nobel N.V. (AkzoNobel) today reported positive volume development in all three Business Areas. Second quarter revenue of €3,710 million was 4 percent lower compared with the same quarter last year. The decrease was mainly due to 5 percent adverse currency effects.
Operating income improved 10 percent to €353 million (2013: €322 million), leading to an increase in net income attributable to shareholders of €205 million (2013: €184 million on a comparable basis). Excluding restructuring costs, return on sales improved in all three Business Areas, with an overall ROS of 9.5 percent (2013: 8.3 percent).
"With the publication of the Q2 figures, the results of our ongoing commitment to organic growth and operational efficiency continue to be visible. We are operating in a volatile market, but we managed to increase volumes in all three Business Areas, and for the fourth consecutive quarter we saw positive progress in our year-on-year ROS. Compared to 2013, net income attributable to shareholders increased on a comparable basis. This quarter also highlighted some great examples of AkzoNobel’s commitment to innovation and sustainability, such as the opening of our new membrane electrolysis plant in Germany, the €6.5 million investment to expand the research center at our Performance Coatings site in China, and the start-up of our new €80 million Imperatriz Chemical Island in Brazil. We also launched our Human Cities initiative. These developments will not only help to further enhance our operational efficiency and stimulate organic growth, but will also boost our market leading positions, ensuring that we are on track to deliver on our 2015 financial targets."